Autres langues

17/07 Angelini conquista Catalyst; CDP Equity sale oltre il 23%
16/07 La farmacéutica Angelini Pharma completa la compra de Catalyst por 4.100 millones de dólares
16/07 Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals
16/07 Deals of the day-Mergers and acquisitions
16/07 Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst
16/07 Angelini Pharma : completa acquisizione Catalyst Pharmaceuticals per 4,1 mld $
16/07 Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals
15/07 Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from S&P 1000
15/07 Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from S&P 600 Health Care
15/07 Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from S&P Composite 1500
15/07 Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from S&P 600
15/07 Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from S&P Biotechnology Select Industry Index
15/07 Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from S&P TMI Index
15/07 Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from S&P Global BMI Index
15/07 Catalyst Pharmaceuticals, Inc.(NasdaqGM:CPRX) dropped from NASDAQ Composite Index
15/07 Angelini Pharma S.p.a. completed the acquisition of Catalyst Pharmaceuticals, Inc. from a group of shareholders.
14/07 Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from Russell Small Cap Comp Growth Index
14/07 Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from Russell 2000 Growth Index
14/07 Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from Russell 2000 Defensive Index
14/07 Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from Russell Small Cap Comp Growth Benchmark
14/07 Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from Russell 3000E Growth Benchmark
14/07 Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from Russell 3000 Growth Benchmark
14/07 Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from Russell 3000 Growth Index
14/07 Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from Russell 2000 Growth Benchmark
14/07 Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from Russell 2500 Growth-Defensive Index
Aucun résultat pour cette recherche